CAPSTONE: An Exagen Podcast

Exagen Podcast

The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove? Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler O’Malley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers.

Episodes

  1. Episode 4: The Questions

    07/06/2022

    Episode 4: The Questions

    What are the highlights surrounding the CAPSTONE study? How does it prove that AVISE testing is improving the diagnostic odyssey? Join Dr. Debra Zack and Tyler O’Malley as they summarize the discoveries of the CAPSTONE study, highlight the key components, and expand on their thoughts on what this means for the future of lupus—and autoimmune—diagnostics.

    16 min

  2. 07/06/2022

    Episode 3: The Application

    The results of the CAPSTONE study are exciting and encouraging, but what do they mean for providers and patients from an application perspective? And what impact will this have on payors? Join Dr. Debra Zack and Tyler O’Malley as they take the results from the CAPSTONE study and apply them to the diagnostic journey for both patients and providers. From insurance coverage to timely and accurate diagnosis, they explore the implications of the study in real-time.

    16 min
  3. Episode 2: The Study

    07/06/2022

    Episode 2: The Study

    Conducting the largest utility study in lupus diagnostics means big numbers, a long timeline, and intriguing results. What was the methodology, conclusion, and results of the CAPSTONE study? Join Dr. Debra Zack and Tyler O’Malley as they breakdown the process of the study, expand on the patient cohorts, and go into detail on the conclusive evidence that showcases the superiority of the AVISE lupus test compared to current standard of care.

    15 min
  4. Episode 1: The Unmet Need

    07/06/2022

    Episode 1: The Unmet Need

    What has the development of lupus diagnostics looked like over the years? Why is proving the effectiveness of the AVISE Lupus test so important? Join Dr. Debra Zack and Tyler O’Malley as they delve into the history of lupus diagnostics, look at the current landscape, and explain the unmet need that prompted Exagen to conduct the largest ever comparative utility study in lupus diagnostics.

    14 min
  • 4 Episodes

About

The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove? Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler O’Malley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers.

Information